Nisa Investment Advisors
KYTX icon

Nisa Investment Advisors’s Kyverna Therapeutics KYTX Stock Holding History

Nisa Investment Advisors’s Portfolio KYTX Stock Details KYTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.68K Hold
301
– – ﹤0.01% 2715
2026
Q1 		$2.6K Hold
301
– – ﹤0.01% 2577
2025
Q4 		$2.83K Hold
301
– – ﹤0.01% 2553
2025
Q3 		$1.81K Hold
301
– – ﹤0.01% 2642
2025
Q2 		$924 Buy
301
+42
+16% +$104 ﹤0.01% 2752
2025
Q1 		$500 Sell
259
-105
-29% -$310 ﹤0.01% 2793
2024
Q4 		$1.36K Sell
364
-842
-70% -$4.03K ﹤0.01% 2601
2024
Q3 		$5.9K Buy
+1,206
New +$9.3K ﹤0.01% 2193

Other funds holding KYTX

GGI
GordonMD Global Investments Beverely Hills, California $207M AUM
GS
Gilead Sciences Foster City, California $1.65B AUM 166.99% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
IHG
Insight Holdings Group New York $1.32B AUM 1.62% 1-Year Est. Return

Nisa Investment Advisors's KYTX Position: Q2 2026 in Review

Nisa Investment Advisors held its Kyverna Therapeutics (KYTX) position steady in Q2 2026 at 301 shares worth $2.68K. The position accounts for ﹤0.01% of the portfolio, ranked #2715.

Nisa Investment Advisors first reported a position in KYTX in Q3 2024 and has held it in 8 quarters since. The position peaked at $5.9K in Q3 2024. 120 funds tracked by Wall St. Rank hold KYTX as of Q2 2026.

  • Nisa Investment Advisors held 301 shares of Kyverna Therapeutics worth $2.68K as of Q2 2026.
  • Nisa Investment Advisors left its Kyverna Therapeutics share count unchanged in Q2 2026.
  • Kyverna Therapeutics made up ﹤0.01% of Nisa Investment Advisors's portfolio in Q2 2026, its #2715 holding.
  • Nisa Investment Advisors first reported a position in Kyverna Therapeutics in Q3 2024 and has held it in 8 quarters since.
  • Nisa Investment Advisors's Kyverna Therapeutics position peaked at $5.9K in Q3 2024.
  • 120 funds tracked by Wall St. Rank held Kyverna Therapeutics as of Q2 2026.

Based on Nisa Investment Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.